KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Assets Average (2016 - 2025)

AbbVie (ABBV) has disclosed Assets Average for 13 consecutive years, with $133.9 billion as the latest value for Q4 2025.

  • On a quarterly basis, Assets Average fell 3.85% to $133.9 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $133.9 billion, a 3.85% decrease, with the full-year FY2025 number at $134.6 billion, changed 0.28% from a year prior.
  • Assets Average was $133.9 billion for Q4 2025 at AbbVie, down from $135.5 billion in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $150.5 billion in Q1 2021 to a low of $133.9 billion in Q4 2025.
  • A 5-year average of $141.0 billion and a median of $140.9 billion in 2022 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: skyrocketed 66.97% in 2021, then fell 6.01% in 2025.
  • AbbVie's Assets Average stood at $147.7 billion in 2021, then dropped by 5.17% to $140.1 billion in 2022, then decreased by 3.28% to $135.5 billion in 2023, then grew by 2.82% to $139.3 billion in 2024, then fell by 3.85% to $133.9 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Assets Average are $133.9 billion (Q4 2025), $135.5 billion (Q3 2025), and $136.7 billion (Q2 2025).